Regulus Therapeutics Inc.

NASDAQ (USD): Regulus Therapeutics Inc. (RGLS)

Last Price

1.61

Today's Change

+0.03 (1.89%)

Day's Change

1.58 - 1.65

Trading Volume

234,129

Overview

Market Cap

105 Million

Shares Outstanding

65 Million

Avg Volume

797,204

Avg Price (50 Days)

1.66

Avg Price (200 Days)

1.82

PE Ratio

-1.34

EPS

-1.20

Earnings Announcement

07-Nov-2024

Previous Close

1.58

Open

1.64

Day's Range

1.585 - 1.65

Year Range

1.08 - 3.79

Trading Volume

234,129

Price Change Highlight

1 Day Change

1.90%

5 Day Change

3.21%

1 Month Change

1.26%

3 Month Change

-35.08%

6 Month Change

-33.74%

Ytd Change

22.90%

1 Year Change

-3.01%

3 Year Change

-78.53%

5 Year Change

-81.06%

10 Year Change

-99.82%

Max Change

-99.68%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Discussions
Be the first to like this. Showing 1 of 1 comments

actvtrader

I like the 50.00 price target for yahoo!

2014-10-22 15:48

Post a Comment